Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,648 JPY | -0.53% | -0.56% | -4.44% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.44% | 990M | - | ||
-3.54% | 185B | C+ | ||
-0.58% | 109B | C | ||
-2.74% | 68.54B | A | ||
+4.84% | 51.74B | B- | ||
+10.40% | 45.22B | B- | ||
+3.23% | 41.74B | B+ | ||
+2.87% | 26.69B | B | ||
+4.61% | 26.83B | A- | ||
+11.47% | 25.63B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 7817 Stock
- Ratings Paramount Bed Holdings Co., Ltd.